Data from pivotal Phase 3 trial in CHB-associated liver fibrosis expected in Q2 2025Commercial launch in the PRC of generic nintedanib for the ...
Chennai: For nearly six weeks, a flurry of bureaucratic activity has gripped the secretariat, with files shuttling between departments and legal exper.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback